RxDoctor Payments Data

Kartik Swaminathan, MD

Pain Medicine · Smyrna, DENPI 1548234107

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,964 of the $2,931 with a category attached, or 67.0%. 18 manufacturers reported payments, led by Medtronic at 50.0% of the total. Reporting peaked in 2019 at $1,477 and has fallen 70.8% since, to $432 in 2025. That places this record below the midpoint for pain medicine clinicians in DE, where the typical reported total is $3,435.

$2,931in general payments, 2019–2025

Across 71 payments — averaging $41.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Stryker$364
  • Abbott$285
  • Daiichi Sankyo Inc.$166
  • Scilex Pharmaceuticals Inc.$135
  • Microtransponder, Inc.$95
  • plus $421 from 12 others

What the payments were for

  • Travel & lodging$96733%
  • Food & beverage$1,96467%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,931 in reported general payments places this provider in the 45th percentile of 31 pain medicine providers in Delaware.

See all pain medicine providers in Delaware

Medicare billing

Part B allowed, 2024
$186,399
Medicare patients
405
Services billed
1,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl195$1,599
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen64$1,562
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$1,372
Gabapentin83$1,182
Oxycodone Hcl51$855
Meloxicam107$583
Acetaminophen-CodeineAcetaminophen With Codeine39$462
Morphine Sulfate ErMorphine Sulfate16$348
Tramadol Hcl93$341
Celecoxib16$269
Diazepam16$52

Paid to pharmacies, not to this prescriber.

Other pain medicine in Smyrna

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →